Cargando…
Use of thiopurines in inflammatory bowel disease: an update
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD has come under the spotlight. 5-Aminosalicylates, corticosteroids, immunosuppressive agents and biologics are the b...
Autores principales: | Singh, Arshdeep, Mahajan, Ramit, Kedia, Saurabh, Dutta, Amit Kumar, Anand, Abhinav, Bernstein, Charles N., Desai, Devendra, Pai, C. Ganesh, Makharia, Govind, Tevethia, Harsh Vardhan, Mak, Joyce WY, Kaur, Kirandeep, Peddi, Kiran, Ranjan, Mukesh Kumar, Arkkila, Perttu, Kochhar, Rakesh, Banerjee, Rupa, Sinha, Saroj Kant, Ng, Siew Chien, Hanauer, Stephen, Verma, Suhang, Dutta, Usha, Midha, Vandana, Mehta, Varun, Ahuja, Vineet, Sood, Ajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831775/ https://www.ncbi.nlm.nih.gov/pubmed/33845546 http://dx.doi.org/10.5217/ir.2020.00155 |
Ejemplares similares
-
Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020) -
Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
por: Sood, Ajit, et al.
Publicado: (2021) -
Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
por: Sood, Ajit, et al.
Publicado: (2020) -
Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
por: Midha, Vandana, et al.
Publicado: (2018) -
Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
por: Singh, Arshdeep, et al.
Publicado: (2023)